Clinical trial
24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations
NCT00397241 · Aristotle University Of Thessaloniki, Other · Completed
Key facts
| NCT number | NCT00397241 |
|---|---|
| Title | 24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations |
| Official title | 24-hour IOP With DTFC and LTFC Monotherapies and the Adjunctive Therapy of DTFC and Latanoprost in Open-angle Glaucoma Insufficiently Controlled With Latanoprost Monotherapy. |
| Lead sponsor | Aristotle University Of Thessaloniki, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Open-angle Glaucoma |
| Intervention type | Drug |
| Interventions | Drug: dorzolamide/timolol, Drug: latanoprost/timolol, dorzolamide/timolol and latanoprost, placebo (artificial tears) |
| Enrollment | 33 |
| Start date | Sep 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Nov 8, 2006 |
| Last update posted | Dec 19, 2020 |
| Countries | Greece |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: